Jens Siveke
Has participated in:
-
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer
-
T-Helferzellen vom Th1-Th2-Typ : chemokin-induzierte Chemotaxis und Chemokinrezeptor-Expression
-
Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcription
-
T-Helferzellen vom Th1-, Th2-Typ : chemokin-induzierte Chemotaxis und Chemokinrezeptor-Expression